
Palmitoylethanolamide (PEA) and its application in small animal practice with Dr Matthew Muir
Échec de l'ajout au panier.
Veuillez réessayer plus tard
Échec de l'ajout à la liste d'envies.
Veuillez réessayer plus tard
Échec de la suppression de la liste d’envies.
Veuillez réessayer plus tard
Échec du suivi du balado
Ne plus suivre le balado a échoué
-
Narrateur(s):
-
Auteur(s):
À propos de cet audio
In this month's episode we welcome back Dr Matthew Muir to talk about PEA and its application in small animal practice.
Topics discussed include:
- What is palmitoylethanolamide (PEA)?
- Mechanism of actions of PEA.
- Bioavailability of PEA - which form should we use and why?
- PEA has been available since the 1950's, why hasn't it been used more in veterinary medicine?
- CBD vs PEA, how are they similar and how do they differ? When to recommend PEA over CBD.
- Dr Muir discusses the safety profile of palmitoylethanolamide.
- Atopy and PEA - should PEA be used long term or short term?
- Evidence for use of PEA in animals and humans.
- How Dr Muir uses PEA in his practice?
- Matt shares some personal experience of ideal doses for certain conditions.
See omnystudio.com/listener for privacy information.
Ce que les auditeurs disent de Palmitoylethanolamide (PEA) and its application in small animal practice with Dr Matthew Muir
Moyenne des évaluations de clientsÉvaluations – Cliquez sur les onglets pour changer la source des évaluations.
Il n'y a pas encore de critiques pour ce titre.